 Home > Medical News > Latest Medical News > Novartis' new-generation drug Beovu Phase 3 MERLIN study: Intraocular inflammation is higher than aflibercept

Novartis' new-generation drug Beovu Phase 3 MERLIN study: Intraocular inflammation is higher than aflibercept

 Last Update: 2021-06-05
 Source: Internet
 Author: User

Tags

noonan syndrome treatment

media drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Common reasons for abandoning treatment.

It is worth mentioning that Beovu is the first to have an efficacy comparable to Eylea (aflibercept), and to maintain a 3-month dosing interval after a 3-month loading phase in eligible wet-AMD patients.

The active pharmaceutical ingredient of Beovu is brolucizumab (RTH258), which is a humanized single-chain antibody fragment (scfv) that targets all types of vascular endothelial growth factor-A (VEGF-A).

In China, Beovu has entered Phase 3 clinical research, developed for indications such as wet AMD and diabetic retinopathy.

During the "Never Ending" International Innovative Medicine and Equipment Exhibition, Beovu completed the first injection in the country in the Hainan Boao Super Hospital for the treatment of wet AMD.

Original source: Novartis reports one year results of Phase III MERLIN study evaluating Beovu® every four week dosing and provides update on Beovu clinical program

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.